Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $47.6200 (1.34%) ($47.4200 - $49.2900) on Mon. Nov. 7, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 46 | Latest Price | $47.6200(1.34%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BAX declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) SPY(49%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -0.56% in a week (0% probabilities). TLT(-17%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $44.55(-6.45%) | 5 Day Moving Average | $47.02(1.28%) | 10 Day Moving Average | $47.31(0.66%) | 20 Day Moving Average | $47.52(0.21%) | To recent high | -3.1% | To recent low | 5.6% | Market Cap | $24.295b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |